Study of genes in MRKH syndrome and related families
Part of Genetic & congenital, Women’s health & pregnancy clinical trials.
This study looks at DNA (your genes) to better understand Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome. It may help researchers learn more about the condition, and it can include both people with MRKH and healthy family relatives.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have MRKH syndrome, or you are a healthy relative of someone with MRKH
- You (or your parent/guardian if under 18) sign the consent form to join
- You must agree to genetic (DNA) testing as part of the study
- You have not joined a treatment-focused clinical study in the last 30 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether transplanting a uterus from a living related donor can be done safely and can help patients with MRKH type I achieve pregnancy. It also checks risks and safety issues for both the donor and recipient.
This trial looks at the clinical and imaging details of MRKH syndrome, a condition present from birth affecting the uterus and vagina. It aims to improve understanding and care for those with this condition.
This study tracks quality of life and follow-up care in women with Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome, a condition where the uterus and upper vagina are underdeveloped or absent. It compares their experiences to women without MRKH to improve care.
This study collects tissue samples to help researchers learn more about mitochondrial disorders—conditions related to how the body makes energy. It may help by improving genetic understanding for families who suspect an inherited cause.
This study tries to find genetic causes for rare diseases that are not yet understood. It uses a national rare-disease data bank and collects consent from patients and sometimes close family members.
This study aims to learn more about mitochondrial DNA diseases by building a group of people with these conditions. The information gathered may help doctors give better genetic counseling to families.
Hear when a new Mayer Rokitansky Kuster Hauser Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.